Ohio State’s novel DHODH inhibitor enters first human trials

A new therapeutic agent discovered and developed at The Ohio State University will soon be used for cancer treatment at the patient’s bedside as part of a clinical trial.

Doc Travels for Abortion Training; Families Wrongly Separated; Jail Opioid Success

Welcome to the latest edition of Investigative Roundup, highlighting some of the best investigative reporting on healthcare each week. Doc Travels for Abortion Training Politico

September 12, 2024

Deutlich gesteigerter Umsatz im Kerngeschäft und Projekte in Entwicklungs-Pipeline auf Kurs – Biotech Investments

Curatis Holding AG / Key word(s): Half Year Results 16-Sep-2024 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The

September 17, 2024

Rentschler Biopharma Appoints Patrick Cushing as VP Operations for U.S. Subsidiary – Biotech Investments

EQS-News: Rentschler Biopharma SE / Key word(s): Personnel Rentschler Biopharma Appoints Patrick Cushing as VP Operations for U.S. Subsidiary 02.05.2024 / 14:10 CET/CEST The issuer

May 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.